Navigation Links
Angeion Corporation Reports Fourth Quarter and Fiscal Year 2011 Operating Results
Date:12/16/2011

SAINT PAUL, Minn., Dec. 16, 2011 /PRNewswire/ -- Angeion Corporation (NASDAQ: ANGN) today reported financial results for its fourth quarter and fiscal year ended October 31, 2011.

Fourth Quarter Highlights:

  • Revenues of $8.4 million comparable to the fourth quarter of 2010, sequentially up 22% from the third quarter;
  • Service revenue improved 33% to $1.2 million, compared to $888,000 in last year's fourth quarter;
  • GPO (group purchasing organization) revenue during the fourth quarter increased 146% to $1.6 million, compared to $650,000 in the comparable quarter;
  • Gross margin for the fourth quarter remained solid at 56.5%;
  • International sales increased to $1.6 million, a 12% increase over the prior year's fourth quarter; and
  • Strong balance sheet with $9.2 million in cash and investments and no long-term debt.
  • Angeion reported revenue of $8.4 million compared to $8.5 million in the fourth quarter of fiscal 2010. Angeion reported net income of $391,000, or $0.10 per diluted share, versus net income of $410,000, or $0.10 per diluted share, in the comparable quarter last year. Sequentially, revenues in the fourth quarter increased 22% from $6.8 million in the third quarter of fiscal 2011.

    Gross margin for the quarter improved to 56.5% compared to the 56.1% gross margin in the fourth quarter of fiscal year 2010. General and administrative expenses in the fourth quarter of fiscal 2011 decreased 13.4% primarily due to the absence of severance and related one-time expenses in the fourth quarter of fiscal 2010. Management will continue to examine operating expenses going forward to maintain profitability. Sales and marketing expenses decreased 3.4% compared to the fourth quarter of fiscal 2010 while research and development costs increased 33.2% as management dedicated additional resources to advance s
    '/>"/>

    SOURCE Angeion Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12

    Related medicine technology :

    1. Angeion Corporation to Report Fourth Quarter and Fiscal Year 2011 Financial Results on Friday, December 16, 2011
    2. Angeion Corporation Reports Third Quarter Fiscal 2011 Operating Results
    3. Angeion Corporation to Report Third Quarter Fiscal Year 2011 Financial Results on Thursday, September 1, 2011
    4. GP Strategies Shareholders Approve Elimination of Holding Company Structure and Renaming of General Physics Corporation
    5. Sigma-Aldrich Corporation to Present at Upcoming Investor Conference
    6. Celladon Corporation Receives FDA Fast Track Designation for Its Investigational Agent MYDICAR® for the Treatment of Heart Failure
    7. Leatt Corporation Announces 2011 Annual Shareholders Meeting
    8. Radient Pharmaceuticals Corporation Receives $500,000 in New Capital
    9. Radient Pharmaceuticals Corporation Completes Restructurings with Institutional Investors to Limit Conversions and Stock Sales and Provide for Potential Additional Capital
    10. China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2012
    11. Ansell Limited Acquires a Minority Share in Yulex Corporation
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/22/2014)... 21, 2014 Research and Markets  has announced ... Industry Report, 2014-2017" report to their offering. ... Chinese recombinant protein drug market has been expanding rapidly ... and the like. During 2005-2013, sales of recombinant protein ... CAGR of 19.1%, and it is projected that ...
    (Date:11/21/2014)... Calif. and VIENNA, Va. ... innovative in-home care provider that operates in ... a leading provider of remote caregiving technology. Alta will ... and existing client receiving homecare services. Logo ... this technology is the key to providing the kind ...
    (Date:11/21/2014)... 21, 2014  World Hemp Oil, an importer of ... they are now offering legal, organic oil with high ... strains grown in medical marijuana states. People suffering from ... as Parkinson,s, MS, and spinal cord injury, no longer ... because imported CBD Oil Is legal in all states. ...
    Breaking Medicine Technology:China Recombinant Protein Drug Industry Report, 2014-2017 2China Recombinant Protein Drug Industry Report, 2014-2017 3Alta Home Care, Inc. and BeClose Partner to Enable Seniors to Remain in Their Homes Safely and Securely 2New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 2New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 3
    ... Confirm Tapentadol Efficacy and Tolerability for Acute Pain PatientsRARITAN, ... to 30 percent of all people who have surgery ... The use of opioid pain medicines during and after ... side effects. Nausea and vomiting are uncomfortable and bothersome ...
    ... Call to be Held at 9:00 a.m. Eastern Time ... United Therapeutics Corporation (Nasdaq: UTHR ) announced ... (FDA) has approved ADCIRCA(TM) (tadalafil) tablets for oral administration, ... first once-daily phosphodiesterase type 5 (PDE5) inhibitor for the ...
    Cached Medicine Technology:New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 2New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 3New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 4New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 5New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 6New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 7New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 8FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension 2FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension 3FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension 4
    (Date:11/22/2014)... 22, 2014 Discount-Dress.com is an ... the firm is to increase the company’s online market share ... new selection of bridesmaid dresses and announced a bridesmaid dress ... valid until Dec. 30, 2014. All the dresses from this ... , In fact, Discount-Dress.com is very good at manufacturing ...
    (Date:11/22/2014)... Nocturia is defined by the International ... individual has to wake at night one or ... Pipeline Review, H2 2014” provides comprehensive information on ... analysis at various stages, therapeutics assessment by drug ... (RoA) and molecule type, along with latest updates, ...
    (Date:11/22/2014)... 2014 A petition seeking a ban ... in minimally-invasive hysterectomies and fibroid removal surgeries has ... of October, Bernstein Liebhard LLP reports. According to ... November 21st, 2014. That represents an increase of 456 ... on to the campaign.* , The campaign to ban ...
    (Date:11/22/2014)... (HealthDay News) -- The wide variety and complexity of ... for people with food allergies, an expert warns. ... types of food allergies that it can be really ... Guha Krishnaswamy, director of allergy and clinical immunology at ... news release. "If you know you have food ...
    (Date:11/22/2014)... New York, New York (PRWEB) November 22, 2014 ... been filed on behalf of patients who allegedly developed ... move forward in the federal multidistrict litigation now underway ... Liebhard LLP reports. According to court documents, the litigation ... at 10:00 a.m. The Court has directed Lead Counsel ...
    Breaking Medicine News(10 mins):Health News:Bridesmaid Dresses Introduced by Famous Company Discount-Dress.com For The New Year 2015 2Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 2Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 3Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 4Health News:Power Morcellator Petition Gains More than 450 Signatures Since October, Bernstein Liebhard LLP Reports 2Health News:Power Morcellator Petition Gains More than 450 Signatures Since October, Bernstein Liebhard LLP Reports 3Health News:Power Morcellator Petition Gains More than 450 Signatures Since October, Bernstein Liebhard LLP Reports 4Health News:'Tis the Season of Challenges for Those With Food Allergies 2Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 2Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 3
    ... Valley Credits Outsourcing Support as Contributor to Profit Gain ... CSC (NYSE: CSC ) today announced ... business process outsourcing (BPO) services for Aspen Valley Hospital ... disclosed.Under the new agreement, CSC will continue to provide ...
    ... AMERIGROUP Corporation (NYSE: AGP ) announced today ... Nevada began offering healthcare services to individuals enrolled in ... beginning February 1, 2009. "We,re pleased to begin serving ... Carlson, AMERIGROUP Chairman and Chief Executive Officer. "We ...
    ... in your fridge, chances are you,ll try it, experts say , , ... that expired yogurt at the back of the fridge? What about ... , If you,re like most Americans, you,ll take the chance, a ... people would quickly reject at the supermarket are much more eagerly ...
    ... Feb. 2 Despite increasingly dire economic news ... where demand for candidates far exceeds supply. Rehabilitation ... professionals among healthcare staffing agencies and medical facilities. ... employment slowdown, that is not the case for ...
    ... Feb. 2 EDI Health Group, Inc. (EHG), ... for patients, payers and providers in the dental ... (Nasdaq: QSII ) to serve as ... Division (QSI) and its providers and payers. , ...
    ... from celiac diseaseANN ARBOR, Mich., Feb. 2 Dorothy Carpenter ... a bite of bread or pasta could lead to terrible ... of Michigan Health System physician recognized it as celiac ... mass, a cancer that forced doctors to remove part of ...
    Cached Medicine News:Health News:CSC Signs Five-Year Outsourcing Extension With Aspen Valley Hospital 2Health News:AMERIGROUP Health Plan in Nevada Begins Serving Medicaid Enrollees 2Health News:You Own It, You'll Eat It 2Health News:You Own It, You'll Eat It 3Health News:Need for Traveling Therapists Boosts Demand for Lead Services of AlliedTravelCareers.com 2Health News:EDI Health Group Selected by Quality Systems to Facilitate EDI Transactions Between Payers and Large Dental Group Practices 2Health News:EDI Health Group Selected by Quality Systems to Facilitate EDI Transactions Between Payers and Large Dental Group Practices 3Health News:GI Condition Once Thought Rare is Common in U.S. 2Health News:GI Condition Once Thought Rare is Common in U.S. 3
    The Cellabs Rapimal (P.f.) is a rapid and sensitive in vitro immunochromatography assay system for the detection of HRP-2 antigen produced by P. falciparum at the merozoite (red blood cell) stage o...
    Malaria device / strip (3 line, PAN-pLDH, P.f.-HRP2)...
    High sensitive, specific one step immunochromatographic assay for human infectious disease...
    High sensitive, specific one step immunochromatographic assay for human infectious disease...
    Medicine Products: